 |
市场调查报告书
商品编码
1136955
人结核疫苗市场:各给药途径，各年龄层，各流通管道，各地区- 规模，占有率，展望，机会分析，2022年～2030年Human Tuberculosis Vaccine Market, by Route of Administration, by Age Group, by Distribution Channel and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 |
||||||
价格
简介目录
市场动态
结核病预防意识的提高预计将在预测期内推动全球人类结核病疫苗市场的增长。
本调查的主要特征
- 本报告提供以2021年为基准年的预测期间（2022-2030 年）之全球人结核疫苗市场的市场规模和復合年增长率（CAGR %）相关的详细分析。
- 并阐明不同部门市场的潜在收入机会，说明该市场具有魅力的投资主张矩阵。
- 同时并提供市场推动因素和限制、机会、新产品发布或批准、市场趋势、区域前景和主要参与者采用的竞争战略等重要考察。
- 并基于企业亮点，各类型投资组合、主要焦点、财务业绩和市场策略等参数，介绍全球人结核疫苗市场的主要参与者之企业简介。
- 藉由该报告提供的洞察，将能帮助营销人员和公司高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
- 全球人结核疫苗市场报告配合该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
- 利益相关者可以透过全球人结核疫苗市场用于分析的各种战略矩阵来帮助他们更容易做下决策。
目录
第1章 调查目的与前提条件
- 调查目的
- 前提条件
- 简称的说明
第2章 市场展望
- 报告内容
- 市场定义和范围
- 摘要整理
- 市场概述:各给药途径
- 市场概述:各年龄层
- 市场概述:各流通管道
- 市场概述:各地区
- 连贯机遇地图(COM)
第3章 市场动态，法规，及趋势的分析
- 市场动态
- 促进因素
- 阻碍因素
- 商机
- 影响分析
- 主要的发展情形
- 产业趋势
- 法规方案
- 最近产品认证/上市
- PEST分析
- 波特分析
第4章 人结核疫苗的全球市场-冠状病毒(COVID-19)疫情的影响
- 需求的影响
- 医疗保健的影响
- 流行病学
第5章 人结核疫苗的全球市场:各给药途径，2017年～2030年
- 皮内给药(Intradermal
- 经皮给药
第6章 人结核疫苗的全球市场:各年龄层，2017年～2030年
- 小儿科
- 成人
第7章 人结核疫苗的全球市场:各流通管道，2017年～2030年
- 公共
- 私人
第8章 人结核疫苗的全球市场:各地区，2017年～2030年
- 北美
- 美国
- 加拿大
- 南美
- 巴西
- 墨西哥
- 阿根廷
- 其他的南美地区
- 欧洲
- 德国
- 英国
- 法国
- 义大利
- 西班牙
- 俄罗斯
- 其他的欧洲地区
- 亚太地区
- 中国
- 印度
- 日本
- 澳洲
- 韩国
- ASEAN
- 其他亚太地区
- 中东地区
- GCC
- 以色列
- 其他的中东地区
- 非洲
- 南非
- 中非
- 北非
第9章 竞争情形
- 热图分析
- 市场占有率分析
- GlaxoSmithKline Plc
- Merck & Co., Inc.
- Serum Institute of India Pvt. Ltd.
- Valneva SE
- Archivel Farma
- BIOFABRI(Zendal)
- Japan BCG Laboratory
- GreenSignal Bio Pharma Private Limited(GSBPL)
- AJ Vaccines A/S
- Taj Pharma India Limited
- Biomed Lublin S.A.
第10章 章节
- 调查手法的介绍
- 关于出版社
简介目录
Product Code: CMI5209
Mycobacterium tuberculosis is the bacteria that causes tuberculosis. TB germs are most commonly found in the lungs, although they can also be found in the kidney, spine, and brain. Latent tuberculosis infection (LTBI) and tuberculosis illness are two TB-related diseases. The Bacille Calmette-Guerin (BCG) vaccination is used to prevent tuberculosis (TB). In the U.S., this vaccine is not extensively utilized. It is, nevertheless, frequently given to newborns and small children in other countries where tuberculosis is prevalent. The BCG vaccine does not always protect people from contracting tuberculosis. Pediatric tuberculosis is a public health problem of particular importance since it is a marker of recent transmission of tuberculosis.
Market Dynamics
Increasing awareness for prevention of tuberculosis is expected to drive growth of the global human tuberculosis vaccine market during the forecast period. For instance, in March 2022, Johnson & Johnson Philippines Inc., a subsidiary of Johnson & Johnson, and the Philippine Tuberculosis Society Inc. (PTSI), a non-profit, nongovernment organization, rolled out their joint priority project in 2022, a campaign to find the 'missing millions' affected by tuberculosis (TB) among the country's youth and help them improve their lung health with the right treatment
Increasing government initiatives to combat tuberculosis is expected to drive the market growth of global human tuberculosis vaccine market. For instance, in March 2018, the Ministry of Health and Prevention, MOHAP, organized an event in observation of World Tuberculosis Day, under the slogan 'We need leaders to create a world free from tuberculosis'. The event was held to create awareness about the seriousness of tuberculosis and identify its symptoms and ways of transmission.
Key features of the study:
- This report provides an in-depth analysis of the global human tuberculosis vaccine market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global human tuberculosis vaccine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, strategies
- Key companies covered as a part of this study include GlaxoSmithKline Plc, Merck & Co., Inc., Serum Institute of India Pvt. Ltd., Valneva SE, Archivel Farma, BIOFABRI (Zendal), Japan BCG Laboratory, GreenSignal Bio Pharma Private Limited (GSBPL), AJ Vaccines A/S, Taj Pharma India Limited, and Biomed Lublin S.A.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global human tuberculosis vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global human tuberculosis vaccine market
Detailed Segmentation:
- Global Human Tuberculosis Vaccine Market, by Route of Administration :
- Intradermal
- Percutaneous
- Global Human Tuberculosis Vaccine Market, by Age Group :
- Pediatrics
- Adults
- Global Human Tuberculosis Vaccine Market, by Distribution Channel :
- Public
- Private
- Global Human Tuberculosis Vaccine Market, By Region:
- North America
- By Country:
- U.S.
- Canada
- Latin America
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia Pacific
- By Country:
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
- Middle East
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- North America
- Company Profiles
- GlaxoSmithKline Plc *
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Merck & Co., Inc.
- Serum Institute of India Pvt. Ltd.
- Valneva SE
- Archivel Farma
- BIOFABRI (Zendal)
- Japan BCG Laboratory
- GreenSignal Bio Pharma Private Limited (GSBPL)
- AJ Vaccines A/S
- Taj Pharma India Limited
- Biomed Lublin S.A.
- GlaxoSmithKline Plc *
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Route of Administration
- Market Snapshot, By Age Group
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunity
- Impact Analysis
- Key Developments
- Industry Trends
- Regulatory Scenario
- Recent Product Approval/Launches
- PEST Analysis
- Porter's Analysis
4. Global Human Tuberculosis Vaccine Market- Impact of Coronavirus (COVID-19) Pandemic
- Impact on Demand
- Impact on Healthcare
- Epidemiology
5. Global Human Tuberculosis Vaccine Market, By Route of Administration, 2017 - 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Intradermal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
- Percutaneous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Mn)
6. Global Human Tuberculosis Vaccine Market, By Age Group, 2017 - 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Pediatrics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
- Adults
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
7. Global Human Tuberculosis Vaccine Market, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Public
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
- Private
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Mn)
8. Global Human Tuberculosis Vaccine Market, By Region, 2017 - 2030 (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2022 and 2030(%)
- Y-o-Y Growth Analysis, For Regions, 2017 - 2030
- Regional Trends
- North America
- Market Size and Forecast, By Route of Administration, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Age Group, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Route of Administration, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Age Group, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Route of Administration, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Age Group, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Route of Administration, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Age Group, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Route of Administration, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Age Group, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Route of Administration, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Age Group, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Region/Country, 2017 - 2030 (US$ Mn)
- South Africa
- Central Africa
- North Africa
9. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- GlaxoSmithKline Plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Serum Institute of India Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Valneva SE
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Archivel Farma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- BIOFABRI (Zendal)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Japan BCG Laboratory
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- GreenSignal Bio Pharma Private Limited (GSBPL)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- AJ Vaccines A/S
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Taj Pharma India Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Biomed Lublin S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
10. Section
- Research Methodology
- About Us
